GEN also decreased the over‐production of pro‐inflammatory cytokines TNF‐α, IL‐1β and IL‐6, proved GEN could reduce the inflammation during the progress of NAFLD. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.